Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Factors that influence the bleeding phenotype in severe hemophilic patients.

Rendo P, Shafer F, Korth-Bradley JM, Sivamurthy K, Korin J.

Blood Coagul Fibrinolysis. 2013 Oct;24(7):683-90. doi: 10.1097/MBC.0b013e3283614210. Review.

PMID:
24056291
[PubMed - indexed for MEDLINE]
2.

Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy.

Mondorf W, Kalnins W, Klamroth R.

Haemophilia. 2013 Jul;19(4):558-63. doi: 10.1111/hae.12136. Epub 2013 Apr 8.

PMID:
23560639
[PubMed - indexed for MEDLINE]
3.

Outcome in moderate haemophilia.

den Uijl I, Biesma D, Grobbee D, Fischer K.

Blood Transfus. 2014 Jan;12 Suppl 1:s330-6. doi: 10.2450/2012.0091-12. Epub 2012 Nov 20.

PMID:
23245711
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The role of physical medicine and rehabilitation in haemophiliac patients.

De la Corte-Rodriguez H, Rodriguez-Merchan EC.

Blood Coagul Fibrinolysis. 2013 Jan;24(1):1-9. doi: 10.1097/MBC.0b013e32835a72f3. Review.

PMID:
23103725
[PubMed - indexed for MEDLINE]
5.

Personalized prophylaxis.

Collins PW.

Haemophilia. 2012 Jul;18 Suppl 4:131-5. doi: 10.1111/j.1365-2516.2012.02838.x.

PMID:
22726096
[PubMed - indexed for MEDLINE]
6.

Hemophilia management in transfusion medicine.

Poon MC, Card R.

Transfus Apher Sci. 2012 Jun;46(3):299-307. doi: 10.1016/j.transci.2012.03.020. Epub 2012 Apr 13. Review.

PMID:
22503305
[PubMed - indexed for MEDLINE]
7.

Management of muscle haematomas in patients with severe haemophilia in an evidence-poor world.

Sørensen B, Benson GM, Bladen M, Classey S, Keeling DM, McLaughlin P, Yee TT, Makris M.

Haemophilia. 2012 Jul;18(4):598-606. doi: 10.1111/j.1365-2516.2011.02720.x. Epub 2011 Dec 12.

PMID:
22151135
[PubMed - indexed for MEDLINE]
8.

Recommendations for assessment, monitoring and follow-up of patients with haemophilia.

de Moerloose P, Fischer K, Lambert T, Windyga J, Batorova A, Lavigne-Lissalde G, Rocino A, Astermark J, Hermans C.

Haemophilia. 2012 May;18(3):319-25. doi: 10.1111/j.1365-2516.2011.02671.x. Epub 2011 Oct 13. Review.

PMID:
21992772
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study.

Collins P, Faradji A, Morfini M, Enriquez MM, Schwartz L.

J Thromb Haemost. 2010 Jan;8(1):83-9. doi: 10.1111/j.1538-7836.2009.03650.x. Epub 2009 Oct 11.

PMID:
19817995
[PubMed - indexed for MEDLINE]
10.

Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density.

Khawaji M, Akesson K, Berntorp E.

Haemophilia. 2009 Jan;15(1):261-6. doi: 10.1111/j.1365-2516.2008.01912.x. Epub 2008 Nov 3.

PMID:
19149852
[PubMed - indexed for MEDLINE]
11.

Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.

Fischer K, Valentino L, Ljung R, Blanchette V.

Haemophilia. 2008 Jul;14 Suppl 3:196-201. doi: 10.1111/j.1365-2516.2008.01736.x.

PMID:
18510542
[PubMed - indexed for MEDLINE]
12.

Pathogenesis of haemophilic synovitis: clinical aspects.

Hoots WK, Rodriguez N, Boggio L, Valentino LA.

Haemophilia. 2007 Nov;13 Suppl 3:4-9.

PMID:
17822514
[PubMed - indexed for MEDLINE]
13.

Physiotherapy, rehabilitation and sports in countries with limited replacement coagulation factor supply.

Buzzard BM.

Haemophilia. 2007 Sep;13 Suppl 2:44-6.

PMID:
17685924
[PubMed - indexed for MEDLINE]
14.

Short-term oral corticosteroid therapy for acute haemarthrosis in haemophilia patients with high-titre inhibitors.

Medeiros D, Laufenberg JA, Miller KL, Buchanan GR.

Haemophilia. 2007 Jan;13(1):85-9.

PMID:
17212730
[PubMed - indexed for MEDLINE]
15.

Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency.

Valentino LA, Hakobyan N, Kazarian T, Jabbar KJ, Jabbar AA.

Haemophilia. 2004 May;10(3):280-7.

PMID:
15086328
[PubMed - indexed for MEDLINE]
16.

Update on treatment regimens: prophylaxis versus on-demand therapy.

Manco-Johnson MJ.

Semin Hematol. 2003 Jul;40(3 Suppl 3):3-9. Review.

PMID:
14690062
[PubMed - indexed for MEDLINE]
17.

Long-term FEIBA prophylaxis does not prevent progression of existing joint disease.

Hilgartner MW, Makipernaa A, Dimichele DM.

Haemophilia. 2003 May;9(3):261-8.

PMID:
12694515
[PubMed - indexed for MEDLINE]
18.

NovoSeven in immune tolerance therapy.

Brackmann HH, Effenberger E, Hess L, Schwaab R, Oldenburg J.

Blood Coagul Fibrinolysis. 2000 Apr;11 Suppl 1:S39-44.

PMID:
10850563
[PubMed - indexed for MEDLINE]
19.

Treating hemophilia.

Peterson CW.

Am Pharm. 1994 Aug;NS34(8):57-67; quiz 68-9. Review.

PMID:
7942503
[PubMed - indexed for MEDLINE]
20.

[Children with hemorrhagic diathesis: correct diagnostic and therapeutic approach].

Carnelli V, Dozzi M, Gibelli M, Giovanniello A, Riva F, Seidita C, Stucchi C.

Pediatr Med Chir. 1990 Jan-Feb;12(1):1-13. Review. Italian.

PMID:
2198546
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk